HALKUFF DAWN received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/7/2023ACC: 0001867096-23-000097
Director
Since Oct 2021
+42.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
42.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+42.50K
Price / share
—
Trade value
—
% of position
283.3%
6/7/2023
15K→57.50K
Total
Net shares
+42.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/7/2023 | A · Award | +42.50K | — | — | 283.3% | 15K | 57.50K |
| Total | +42.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported